A detailed history of Guggenheim Capital LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 7,649 shares of MEDP stock, worth $2.68 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,649
Previous 6,460 18.41%
Holding current value
$2.68 Million
Previous $2.66 Million 4.14%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $381,169 - $543,717
1,189 Added 18.41%
7,649 $2.55 Million
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $3.5 Million - $3.99 Million
-9,412 Reduced 59.3%
6,460 $2.66 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $2.43 Million - $3.52 Million
8,514 Added 115.71%
15,872 $6.41 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $224,107 - $307,989
-985 Reduced 11.81%
7,358 $2.26 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $447,603 - $538,834
-1,913 Reduced 18.65%
8,343 $2.02 Million
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $89,510 - $114,801
478 Added 4.89%
10,256 $2.46 Million
Q1 2023

May 10, 2023

SELL
$174.31 - $239.52 $719,377 - $988,499
-4,127 Reduced 29.68%
9,778 $1.84 Million
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $394,435 - $583,870
-2,577 Reduced 15.64%
13,905 $2.95 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $41,362 - $52,009
-285 Reduced 1.7%
16,482 $2.59 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $116,659 - $150,554
-896 Reduced 5.07%
16,767 $2.51 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $88,737 - $136,944
-639 Reduced 3.49%
17,663 $2.89 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $883,547 - $1.1 Million
-4,835 Reduced 20.9%
18,302 $3.98 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $108,404 - $126,259
-637 Reduced 2.68%
23,137 $4.38 Million
Q2 2021

Aug 13, 2021

SELL
$158.62 - $194.3 $423,674 - $518,975
-2,671 Reduced 10.1%
23,774 $4.2 Million
Q1 2021

May 13, 2021

SELL
$132.02 - $168.26 $241,992 - $308,420
-1,833 Reduced 6.48%
26,445 $4.34 Million
Q4 2020

Feb 16, 2021

BUY
$109.38 - $149.19 $1.79 Million - $2.44 Million
16,339 Added 136.85%
28,278 $3.94 Million
Q3 2020

Nov 13, 2020

BUY
$92.95 - $130.61 $750,850 - $1.06 Million
8,078 Added 209.22%
11,939 $1.33 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $262,856 - $369,420
3,861 New
3,861 $359,000
Q1 2020

Jun 02, 2020

SELL
$61.71 - $101.95 $263,378 - $435,122
-4,268 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $8,970 - $10,833
128 Added 3.09%
4,268 $359,000
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $133,867 - $184,319
-2,146 Reduced 34.14%
4,140 $348,000
Q2 2019

Aug 14, 2019

BUY
$53.64 - $65.42 $6,865 - $8,373
128 Added 2.08%
6,286 $411,000
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $94,858 - $135,584
-1,921 Reduced 23.78%
6,158 $363,000
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $814,553 - $1.11 Million
-17,342 Reduced 68.22%
8,079 $428,000
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $1.1 Million - $1.62 Million
25,421 New
25,421 $1.52 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.